Balance Sheet
Cash Flow Statement
AmortizationAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evogene (EVGN) Change in Cash (2016 - 2025)

Historic Change in Cash for Evogene (EVGN) over the last 13 years, with Q3 2025 value amounting to -$2.8 million.

  • Evogene's Change in Cash fell 25128.21% to -$2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 million, marking a year-over-year increase of 679152.54%. This contributed to the annual value of -$5.5 million for FY2024, which is 3334.55% up from last year.
  • Per Evogene's latest filing, its Change in Cash stood at -$2.8 million for Q3 2025, which was down 25128.21% from $904000.0 recorded in Q2 2025.
  • Evogene's Change in Cash's 5-year high stood at $7.1 million during Q3 2023, with a 5-year trough of -$7.6 million in Q1 2021.
  • Over the past 5 years, Evogene's median Change in Cash value was -$2.8 million (recorded in 2023), while the average stood at -$1.4 million.
  • As far as peak fluctuations go, Evogene's Change in Cash skyrocketed by 53895.41% in 2021, and later plummeted by 27374.18% in 2022.
  • Evogene's Change in Cash (Quarter) stood at -$5.3 million in 2021, then surged by 45.74% to -$2.9 million in 2022, then plummeted by 127.74% to -$6.6 million in 2023, then surged by 160.74% to $4.0 million in 2024, then crashed by 169.6% to -$2.8 million in 2025.
  • Its Change in Cash stands at -$2.8 million for Q3 2025, versus $904000.0 for Q2 2025 and $4.0 million for Q4 2024.